Cargando…
Controversies in the use & implementation of drug-eluting stent technology
The introduction of drug eluting stents has resulted in dramatic reductions in the rates of restenosis and the need for repeat revascularization. In the last several years, concern has been raised regarding the long-term safety of this technology, particularly in the area of late restenosis and sten...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3612322/ https://www.ncbi.nlm.nih.gov/pubmed/23391788 |
_version_ | 1782264647921958912 |
---|---|
author | Itagaki, Brandon K. Brar, Somjot S. |
author_facet | Itagaki, Brandon K. Brar, Somjot S. |
author_sort | Itagaki, Brandon K. |
collection | PubMed |
description | The introduction of drug eluting stents has resulted in dramatic reductions in the rates of restenosis and the need for repeat revascularization. In the last several years, concern has been raised regarding the long-term safety of this technology, particularly in the area of late restenosis and stent thrombosis. The development of newer anti-restenotic drug coatings, biodegradable polymers and even completely bioabsorbable stents offer the potential to address these limitations. Additional questions that have recently come to the forefront include the optimal duration of dual antiplatelet therapy, the use of platelet reactivity assays and genetic testing and drug eluting stent use in the treatment of acute myocardial infarction. This article will attempt to address these and other areas of controversy in the use and implementation of drug eluting stents. |
format | Online Article Text |
id | pubmed-3612322 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-36123222013-04-24 Controversies in the use & implementation of drug-eluting stent technology Itagaki, Brandon K. Brar, Somjot S. Indian J Med Res Review Article The introduction of drug eluting stents has resulted in dramatic reductions in the rates of restenosis and the need for repeat revascularization. In the last several years, concern has been raised regarding the long-term safety of this technology, particularly in the area of late restenosis and stent thrombosis. The development of newer anti-restenotic drug coatings, biodegradable polymers and even completely bioabsorbable stents offer the potential to address these limitations. Additional questions that have recently come to the forefront include the optimal duration of dual antiplatelet therapy, the use of platelet reactivity assays and genetic testing and drug eluting stent use in the treatment of acute myocardial infarction. This article will attempt to address these and other areas of controversy in the use and implementation of drug eluting stents. Medknow Publications & Media Pvt Ltd 2012-12 /pmc/articles/PMC3612322/ /pubmed/23391788 Text en Copyright: © The Indian Journal of Medical Research http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Itagaki, Brandon K. Brar, Somjot S. Controversies in the use & implementation of drug-eluting stent technology |
title | Controversies in the use & implementation of drug-eluting stent technology |
title_full | Controversies in the use & implementation of drug-eluting stent technology |
title_fullStr | Controversies in the use & implementation of drug-eluting stent technology |
title_full_unstemmed | Controversies in the use & implementation of drug-eluting stent technology |
title_short | Controversies in the use & implementation of drug-eluting stent technology |
title_sort | controversies in the use & implementation of drug-eluting stent technology |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3612322/ https://www.ncbi.nlm.nih.gov/pubmed/23391788 |
work_keys_str_mv | AT itagakibrandonk controversiesintheuseimplementationofdrugelutingstenttechnology AT brarsomjots controversiesintheuseimplementationofdrugelutingstenttechnology |